Operating Expenses

Impairment of Intangible Assets

Amgen Impairment of Intangible Assets decreased by 100.0% to $0.00 in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 100.0%, from $800.00M to $0.00. This increase may warrant attention — for this metric, lower values are generally preferred.

Analysis

StatementIncome Statement
SectionOperating Expenses
CategoryRisk
SignalLower is better
VolatilityVolatile
First reportedQ1 2023
Last reportedQ1 2026Apr 30, 2026

How to read this metric

An increase signals potential issues with past acquisitions or declining market value of specific product lines.

Detailed definition

Represents a non-cash charge taken when the carrying value of an intangible asset exceeds its fair value. This indicates...

Peer comparison

Occurs across all industries; peers may report these periodically following large-scale acquisitions.

Metric ID: amgn_impairment_of_intangible_assets

Historical Data

11 periods
 Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q3 '25Q1 '26
Value$212.75M$212.75M$212.75M$212.75M$68.00M$0.00$61.00M$30.00M$800.00M$400.00M$0.00
QoQ Change+0.0%+0.0%+0.0%-68.0%-100.0%-50.8%>999%-50.0%-100.0%
YoY Change-68.0%-100.0%-71.3%-85.9%>999%+555.7%-100.0%
Range$0.00$800.00M
CAGR-100.0%
Avg YoY Growth+172.4%
Median YoY Growth-71.3%
Current Streak2 quarters decline

Frequently Asked Questions

What is Amgen's impairment of intangible assets?
Amgen (AMGN) reported impairment of intangible assets of $0.00 in Q1 2026.
How has Amgen's impairment of intangible assets changed year-over-year?
Amgen's impairment of intangible assets decreased by 100.0% year-over-year, from $800.00M to $0.00.
What does impairment of intangible assets mean?
A write-down in the value of intangible assets when they are no longer worth as much as previously recorded.